An exploratory trial of a single dose of CAM2043 (treprostinil subcutaneous depot) in SSc-related RP.

Herrick AL, Murray A, Dinsdale G, Manning J, Chukwu C, Alvarez Fernandez M, Axling U, Seibold JR, Tiberg F

Open source

DOI
10.1093/rheumatology/keaf291
Published
2025 Oct 1
Container
Rheumatology (Oxford, England)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/rheumatology/keaf291,
  title = {An exploratory trial of a single dose of CAM2043 (treprostinil subcutaneous depot) in SSc-related RP.},
  author = {Herrick AL and Murray A and Dinsdale G and Manning J and Chukwu C and Alvarez Fernandez M and Axling U and Seibold JR and Tiberg F},
  year = {2025},
  journal = {Rheumatology (Oxford, England)},
  doi = {10.1093/rheumatology/keaf291},
  url = {https://doi.org/10.1093/rheumatology/keaf291}
}

RIS

TY  - JOUR
TI  - An exploratory trial of a single dose of CAM2043 (treprostinil subcutaneous depot) in SSc-related RP.
AU  - Herrick AL
AU  - Murray A
AU  - Dinsdale G
AU  - Manning J
AU  - Chukwu C
AU  - Alvarez Fernandez M
AU  - Axling U
AU  - Seibold JR
AU  - Tiberg F
PY  - 2025
JO  - Rheumatology (Oxford, England)
DO  - 10.1093/rheumatology/keaf291
UR  - https://doi.org/10.1093/rheumatology/keaf291
ER  - 

APA

AL, H., A, M., G, D., J, M., C, C., M, A. F., U, A., JR, S., & F, T. (2025). An exploratory trial of a single dose of CAM2043 (treprostinil subcutaneous depot) in SSc-related RP.. Rheumatology (Oxford, England). https://doi.org/10.1093/rheumatology/keaf291

Source records